• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有心力衰竭和吸食冰毒的患者的临床特征和结局。

Clinical Characteristics and Outcomes of Patients With Heart Failure and Methamphetamine Abuse.

机构信息

Division of Cardiovascular Medicine, Department of Medicine, University of California, San Diego, La Jolla, California.

Division of Cardiovascular Medicine, Department of Medicine, University of California, San Diego, La Jolla, California.

出版信息

J Card Fail. 2020 Mar;26(3):202-209. doi: 10.1016/j.cardfail.2019.10.002. Epub 2019 Oct 13.

DOI:10.1016/j.cardfail.2019.10.002
PMID:31618697
Abstract

BACKGROUND

Despite a global epidemic of methamphetamine abuse, methamphetamine-associated heart failure (MethHF) remains poorly understood. We sought to evaluate characteristics and outcomes for patients with MethHF.

METHODS

We reviewed the electronic health records of the University of California, San Diego, from 2005 to 2016. We compared characteristics and outcomes between 896 patients with MethHF and 20,576 patients with heart failure (HF) identified using diagnosis codes, urine toxicology, and natriuretic peptides.

RESULTS

Compared with HF, patients with MethHF were younger (50±10 vs 67±16 years), predominantly male (72% vs 54%), and had more psychiatric and substance use comorbidities, including mood/anxiety disorders (29% vs 16%) and opioid use (44% vs 7%). MethHF had a higher 5-year HF readmission rate (64±4% vs 45±1%; hazard ratio [HR] 1.53, P < .001) and a lower 10-year total mortality rate (25±3% vs 28±1%; HR 0.85, P = .09). Predictors of poor outcomes included mood/anxiety disorders (HF readmission HR 1.41, P = .04) and opioid abuse (mortality HR 1.52, P = .04).

CONCLUSIONS

Patients with MethHF are frequently encumbered by psychiatric and substance abuse comorbidities, and carry a substantial risk of HF readmission and mortality. Comprehensive efforts are needed to stem this emerging epidemic.

摘要

背景

尽管冰毒滥用在全球范围内流行,但与冰毒相关的心力衰竭(MethHF)仍然知之甚少。我们试图评估患有 MethHF 的患者的特征和结局。

方法

我们回顾了 2005 年至 2016 年期间加利福尼亚大学圣地亚哥分校的电子健康记录。我们比较了 896 例 MethHF 患者和 20576 例通过诊断代码、尿液毒物学和利钠肽确定的心力衰竭(HF)患者的特征和结局。

结果

与 HF 相比,MethHF 患者更年轻(50±10 岁 vs 67±16 岁),主要为男性(72% vs 54%),并有更多的精神和物质使用合并症,包括情绪/焦虑障碍(29% vs 16%)和阿片类药物使用(44% vs 7%)。MethHF 的 HF 5 年再入院率较高(64±4% vs 45±1%;危险比[HR]1.53,P<0.001),10 年总死亡率较低(25±3% vs 28±1%;HR 0.85,P=0.09)。不良结局的预测因素包括情绪/焦虑障碍(HF 再入院 HR 1.41,P=0.04)和阿片类药物滥用(死亡率 HR 1.52,P=0.04)。

结论

患有 MethHF 的患者经常伴有精神和物质滥用合并症,HF 再入院和死亡的风险很大。需要采取综合措施来遏制这一新兴的流行。

相似文献

1
Clinical Characteristics and Outcomes of Patients With Heart Failure and Methamphetamine Abuse.患有心力衰竭和吸食冰毒的患者的临床特征和结局。
J Card Fail. 2020 Mar;26(3):202-209. doi: 10.1016/j.cardfail.2019.10.002. Epub 2019 Oct 13.
2
Characteristics and Outcomes of Methamphetamine Abuse Among Veterans With Heart Failure.心力衰竭退伍军人中甲基苯丙胺滥用的特征和结局。
Am J Cardiol. 2019 Sep 15;124(6):907-911. doi: 10.1016/j.amjcard.2019.05.068. Epub 2019 Jun 26.
3
Methamphetamine-Associated Heart Failure Hospitalizations Across the United States: Geographic and Social Disparities.美国各地与甲基苯丙胺相关的心力衰竭住院情况:地理和社会差异
J Am Heart Assoc. 2021 Aug 17;10(16):e018370. doi: 10.1161/JAHA.120.018370. Epub 2021 Aug 7.
4
Socioeconomic Burden of Rising Methamphetamine-Associated Heart Failure Hospitalizations in California From 2008 to 2018.2008 年至 2018 年加利福尼亚州与甲基苯丙胺相关的心衰住院患者的社会经济负担。
Circ Cardiovasc Qual Outcomes. 2021 Jul;14(7):e007638. doi: 10.1161/CIRCOUTCOMES.120.007638. Epub 2021 Jul 13.
5
Echocardiographic Parameters and Outcomes in Methamphetamine-Associated Heart Failure: A Propensity Score-Weighted Analysis.甲基苯丙胺相关性心力衰竭的超声心动图参数与预后:一项倾向评分加权分析
Cardiol Res. 2022 Apr;13(2):81-87. doi: 10.14740/cr1364. Epub 2022 Apr 5.
6
Methamphetamine-associated heart failure: a systematic review of observational studies.甲基苯丙胺相关的心力衰竭:观察性研究的系统评价
Heart. 2023 Jan 11;109(3):168-177. doi: 10.1136/heartjnl-2022-321610.
7
The Impact of Substance Abuse on Heart Failure Hospitalizations.物质滥用对心力衰竭住院的影响。
Am J Med. 2020 Feb;133(2):207-213.e1. doi: 10.1016/j.amjmed.2019.07.017. Epub 2019 Jul 29.
8
Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.植入式心脏复律除颤器用于一级预防的心力衰竭患者合并症与预后的关系
J Am Heart Assoc. 2015 Aug 6;4(8):e002061. doi: 10.1161/JAHA.115.002061.
9
Determinants and Impact of Heart Failure Readmission Following Transcatheter Aortic Valve Replacement.经导管主动脉瓣置换术后心力衰竭再入院的决定因素及影响
Circ Cardiovasc Interv. 2020 Jul;13(7):e008959. doi: 10.1161/CIRCINTERVENTIONS.120.008959.
10
Association between depression and readmission of heart failure: A national representative database study.抑郁与心力衰竭再入院的关联:一项全国代表性数据库研究。
Prog Cardiovasc Dis. 2020 Sep-Oct;63(5):585-590. doi: 10.1016/j.pcad.2020.03.014. Epub 2020 Mar 26.

引用本文的文献

1
Methamphetamine-associated heart failure: Clinical characteristics and outcomes in a safety net population.甲基苯丙胺相关性心力衰竭:安全网人群中的临床特征及结局
Heart Lung. 2025 Mar-Apr;70:214-222. doi: 10.1016/j.hrtlng.2024.11.012. Epub 2024 Dec 28.
2
Cardiomyopathy-Associated Hospital Admissions Among Methamphetamine Users: Geographical and Social Disparities.甲基苯丙胺使用者中与心肌病相关的住院情况:地理和社会差异
JACC Adv. 2024 Mar 13;3(7):100840. doi: 10.1016/j.jacadv.2024.100840. eCollection 2024 Jul.
3
Methamphetamine Toxicities and Clinical Management.
冰毒毒性及其临床管理。
NEJM Evid. 2023 Dec;2(12):EVIDra2300160. doi: 10.1056/EVIDra2300160. Epub 2023 Nov 28.
4
Omega-3 supplementation and outcomes of heart failure: A systematic review of clinical trials.ω-3 补充剂与心力衰竭结局:临床试验的系统评价。
Medicine (Baltimore). 2024 Jan 19;103(3):e36804. doi: 10.1097/MD.0000000000036804.
5
Nanowired Delivery of Mesenchymal Stem Cells with Antioxidant Compound H-290/51 Reduces Exacerbation of Methamphetamine Neurotoxicity in Hot Environment.纳米载体递送间充质干细胞与抗氧化化合物 H-290/51 可减轻热环境中甲基苯丙胺神经毒性的恶化。
Adv Neurobiol. 2023;32:317-352. doi: 10.1007/978-3-031-32997-5_8.
6
A Mixed-methods Evaluation of an Addiction/Cardiology Pilot Clinic With Contingency Management for Patients With Stimulant-associated Cardiomyopathy.一项针对兴奋剂相关性心肌病患者采用药物奖励法的成瘾/心脏病学试点诊所的混合方法评估。
J Addict Med. 2023;17(3):312-318. doi: 10.1097/ADM.0000000000001110. Epub 2022 Dec 5.
7
Substance use and medical outcomes in those age 50 and older involving cocaine and metamfetamine reported to United States poison centers.50 岁及以上人群中涉及可卡因和苯丙胺的物质使用与医疗结果:美国中毒控制中心报告。
Clin Toxicol (Phila). 2023 May;61(5):400-407. doi: 10.1080/15563650.2023.2185494. Epub 2023 Apr 21.
8
Cardiovascular magnetic resonance imaging characteristics in patients with methamphetamine-associated cardiomyopathy.与甲基苯丙胺相关的心肌病患者的心血管磁共振成像特征。
J Cardiovasc Magn Reson. 2022 Dec 1;24(1):67. doi: 10.1186/s12968-022-00898-6.
9
Effects of moderate-intensity exercise on social health and physical and mental health of methamphetamine-dependent individuals: A randomized controlled trial.中等强度运动对甲基苯丙胺依赖者社会健康及身心健康的影响:一项随机对照试验
Front Psychiatry. 2022 Sep 23;13:997960. doi: 10.3389/fpsyt.2022.997960. eCollection 2022.
10
Case Report Highlighting Cardiovascular Effects of Concomitant Use of Methamphetamine and Marijuana.病例报告:强调甲基苯丙胺和大麻同时使用对心血管的影响
Cureus. 2022 Aug 10;14(8):e27866. doi: 10.7759/cureus.27866. eCollection 2022 Aug.